🇺🇸 Colistin Sodium Methanesulfonate in United States

25 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Klebsiella Infection — 4 reports (16%)
  2. Condition Aggravated — 3 reports (12%)
  3. Drug Resistance — 3 reports (12%)
  4. Multiple-Drug Resistance — 3 reports (12%)
  5. Sepsis — 3 reports (12%)
  6. Cataract — 2 reports (8%)
  7. Mitral Valve Disease — 2 reports (8%)
  8. Off Label Use — 2 reports (8%)
  9. Pustular Psoriasis — 2 reports (8%)
  10. Alanine Aminotransferase Increased — 1 report (4%)

Source database →

Colistin Sodium Methanesulfonate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Colistin Sodium Methanesulfonate approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Colistin Sodium Methanesulfonate in United States?

Chiang Mai University is the originator. The local marketing authorisation holder may differ — check the official source linked above.